Welcome to LookChem.com Sign In|Join Free

CAS

  • or

89459-38-1

Post Buying Request

89459-38-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

89459-38-1 Usage

General Description

2-Iodo-4-nitrobenzoic acid is a chemical compound with the molecular formula C7H4INO4. It is an aromatic compound that contains both a nitro group and an iodo group attached to a benzene ring. 2-Iodo-4-nitrobenzoic acid is commonly used as a building block in the synthesis of various pharmaceutical and organic compounds due to its ability to participate in a variety of organic reactions. It is also used as a reagent in the preparation of other complex chemical compounds. 2-Iodo-4-nitrobenzoic acid is a yellow crystalline solid that is slightly soluble in water and soluble in organic solvents, making it versatile and easily manipulable in a laboratory setting.

Check Digit Verification of cas no

The CAS Registry Mumber 89459-38-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,4,5 and 9 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 89459-38:
(7*8)+(6*9)+(5*4)+(4*5)+(3*9)+(2*3)+(1*8)=191
191 % 10 = 1
So 89459-38-1 is a valid CAS Registry Number.

89459-38-1Relevant articles and documents

-

Jensen,Ploug

, p. 13,14 (1939)

-

Discovery of a novel series of guanidinebenzoates as gut-restricted enteropeptidase and trypsin dual inhibitors for the treatment of metabolic syndrome

Zhang, Xuqing,Zhu, Bin,Sun, Weimei,Wang, Mina,Albarazanji, Kamal,Ghosh, Brahma,Cummings, Maxwell,Lenhard, James,Leonard, James,Macielag, Mark,Lanter, James

supporting information, (2021/03/22)

A novel series of guanidinebenzoate enteropeptidase and trypsin dual inhibitors has been discovered and SAR studies were conducted. Optimization was focused on improving properties for gut restriction, including increased aqueous solubility, lower cellular permeability, and reduced oral bioavailability. Lead compounds were identified with efficacy in a mouse fecal protein excretion study.

PARA-AMINO-BENZYL LINKERS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN CONJUGATES

-

Page/Page column 93, (2021/11/26)

The present invention relates to para-amino-benzyl linker compounds useful for linking drug moieties to antibodies, to linker-drug compounds in which said para-amino-benzyl linker compounds are covalently linked to drug moieties, and to antibody-drug conjugates in which said para-amino-benzyl linker compounds are covalently linked to drug wherein said drug is enzymatically cleaved from the conjugate at a particular cell or tissue type targeted by said antibody.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 89459-38-1